• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Topics » General Psychiatry

General Psychiatry
General Psychiatry RSS Feed RSS

Fact Sheet

Natural Treatments General Prescribing Tips

January 1, 2026
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

If you’re interested in natural treatments (also known as complementary and alternative medicine, or CAM), you will likely recommend various strategies.



Read More
LithiumOrate_sm.png
Clinical Update

Managing the Side Effects of Lithium

January 1, 2026
Jesse Koskey, MD.
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Jesse Koskey, MD. Associate Clinical Professor, Department of Psychiatry and Behavioral Sciences, UC Davis Health, Sacramento, CA.

Dr. Koskey has no financial relationships with companies related to this material.

Lithium’s reputation for harsh side effects keeps many patients away—but most are manageable with smart, evidence-based care.


Read More
Expert Q&A

Delusions, Conspiracies, and False Beliefs

January 1, 2026
Joseph M. Pierre, MD.
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Joseph Pierre, MD
Clinical Professor, Department of Psychiatry and Behavioral Sciences, University of California, San Francisco.
Dr. Pierre has no financial relationships with companies related to this material.

Dr. Joseph Pierre helps us recognize when a strong belief crosses the line into delusion.


Read More
Research Update

Better Together? Brexpiprazole and Sertraline for PTSD

January 1, 2026
Dominic Le, MD
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Dominic Le, MD. Dr. Le has no financial relationships with companies related to this material.

When standard PTSD meds fall short, one unlikely combination quietly delivers stronger, broader symptom relief.


Read More
Research Update

Smoking Cessation After Initial Failure

January 1, 2026
Dee Rapposelli
From The Carlat Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Dee Rapposelli. Ms. Rapposelli has no financial relationships with companies related to this material.

Most smokers relapse—but a clever second-round strategy might finally tip the odds in their favor.


Read More
Fact Sheet

Xanomeline/Trospium (Cobenfy) Fact Sheet for General Psychiatry

January 1, 2026
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Cobenfy is a novel antipsychotic that acts through the muscarinic acetylcholine system rather than the traditional dopamine pathways.



Read More
Fact Sheet

Risperidone (Risperdal) Fact Sheet [G] for General Psychiatry

January 1, 2026
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Tried and true, risperidone’s moderate side effect profile has led to its wide use, and many clinicians consider it their antipsychotic of choice for first-episode psychotic disorders. 



Read More
Fact Sheet

Olanzapine (Lybalvi, Symbyax, Zyprexa) Fact Sheet [G] for General Psychiatry

January 1, 2026
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Carlat and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Many consider olanzapine to be more effective than other antipsychotics and just below clozapine in overall efficacy. Its strong effectiveness, once-daily dosing, and low QT-prolongation risk are appealing.



Read More
Fact Sheet

Bright Light Therapy Fact Sheet

January 1, 2026
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Light therapy is an effective treatment for seasonal affective disorder and possibly for nonseasonal depression as well. 


Read More
Fact Sheet

Tasimelteon (Hetlioz) Fact Sheet [G]

January 1, 2026
Talia Puzantian, PharmD, BCPP and Daniel Carlat, MD

Dr. Puzantian and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Tasimelteon is a melatonin receptor agonist approved for non-24-hour sleep-wake disorder (N24SWD), which occurs primarily in blind people.


Read More
Previous 1 2 … 12 13 14 15 16 17 18 19 20 … 217 218 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • MFB8e_SpiralCover.png

    Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

    Updated 2026 prescriber's guide.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2730546171.jpg
    General Psychiatry

    ProLivRx: How it Works

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.